Lendon G. Payne

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Polyphosphazene microspheres
- Patent number 6,207,171
- Issue date Mar 27, 2001
- Avant Immunotherapeutics, Inc.
- Lendon G. Payne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyphosphazene polyelectrolyte immunoadjuvants
- Patent number 6,015,563
- Issue date Jan 18, 2000
- Avant Immunotherapeutics, Inc.
- Alexander K. Andrianov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HIV-1 prophylactic composition and method
- Patent number 5,891,444
- Issue date Apr 6, 1999
- Virus Research Institute, Inc.
- Sharon Jenkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Self-assembling replication defective hybrid virus particles
- Patent number 5,858,726
- Issue date Jan 12, 1999
- Therion Biologics
- Lendon Payne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyphosphazene polyelectrolyte immunoadjuvants
- Patent number 5,855,895
- Issue date Jan 5, 1999
- Virus Research Institute
- Alexander K. Andrianov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydrogel microencapsulated vaccines
- Patent number 5,529,777
- Issue date Jun 25, 1996
- Virus Research Institute
- Alexander K. Andrianov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphazene polyelectrolytes as immunoadjuvants
- Patent number 5,494,673
- Issue date Feb 27, 1996
- Virus Research Institute
- Alexander K. Andrianov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Self-assembling replication defective hybrid virus particles
- Patent number 5,420,026
- Issue date May 30, 1995
- Therion Biologics Corporation
- Lendon Payne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lendon G. Payne

Person

Patents Grantslast 30 patents

Polyphosphazene microspheres

Polyphosphazene polyelectrolyte immunoadjuvants

HIV-1 prophylactic composition and method

Self-assembling replication defective hybrid virus particles

Polyphosphazene polyelectrolyte immunoadjuvants

Hydrogel microencapsulated vaccines

Phosphazene polyelectrolytes as immunoadjuvants

Self-assembling replication defective hybrid virus particles